CTRI/2022/11/047325尚未招募3 期
Effect of ceftriaxone sulbactam disodium EDTA combination in treatment of complicated urinary tract infection caused by metallo beta-lactamase producing gram negative bacilli an open label randomised controlled trial
cipla pharmaceuticals0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •COMPLICATED UTI
- •URINE CULTURE GROWING MBL PRODUCING GNB
排除标准
- •MORIBUND PATIENTS
- •MIXED GROWTH IN CULTURE
- •ALLERGY TO MEDICATIONS
研究者
相似试验
已完成
3 期
CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative BacteriaUrinary Tract Infection ComplicatedAcute PyelonephritisNCT03477422Venus Remedies Limited230
已完成
不适用
A randomised controlled study to compare the effect of antibiotic infiltration at the incision site, in preventing surgical site infections in emergency midline surgeries.CTRI/2020/07/026302MAULANA AZAD MEDICAL COLLEGE60
已完成
不适用
The efficacy and safety evaluation of ceftriaxone and sulbactam combination (1.5 gram) in patients with skin and soft tissue infections: an open label, parallel, randomized, prospective comparative trialSkin and soft tissue infectionsInfections and InfestationsISRCTN76443564Ranbaxy Laboratories Ltd (India)400
招募中
不适用
Susceptibility of Ceftriaxone on infectionsCTRI/2022/04/041997Alkem Laboratories
尚未招募
不适用
Monitoring the Efficacy of Artesunate+Sulfadoxine-Pyrimethamine and Artemether Plus Lumefantrine in Uncomplicated Falciparum Malaria in PakistaMalariaACTRN12612001090808Bannu Medical College240